» Articles » PMID: 35693276

Risk Factors and Outcomes of Bronchopleural Fistula After Bronchoplasty in Patients with Non-small Cell Lung Cancer: a Retrospective Multivariate Analysis

Overview
Date 2022 Jun 13
PMID 35693276
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Bronchopleural fistula (BPF) is a rare but severe complication following bronchoplasty. Identification of the risk factors for the development of BPF after bronchoplasty may contribute to better perioperative management, thereby further improving the prognosis of these patients. However, few studies have focused on the risk factors for BPF after bronchoplasty. This study aimed to explore the risk factors and outcomes for BPF after bronchoplasty in patients with non-small cell lung cancer (NSCLC).

Methods: The data of NSCLC patients who underwent bronchoplasty between September 2005 and August 2020 in our institution were retrospectively reviewed. Detailed information on demographic characteristics, preoperative assessment, perioperative outcomes were collected from Western China Lung Cancer Database. The diagnosis of BPF was confirmed by bronchoscopy. Risk factors for BPF were assessed by univariate and multivariate logistic regression analysis.

Results: A total of 503 patients were included in this study, including 132 (26.2%) cases of broncho-vascular plasty, 340 (67.6%) cases of bronchial sleeve lobectomy, and 31 (6.2%) cases of bronchial wedge plasty. Among these patients, 16 (3.2%) developed postoperative BPF. Six patients with BPF died during hospital-stay, including two cases of severe hemoptysis, and four cases of pyothorax and respiratory failure caused by BPF. One of the other ten patients underwent reoperation. After univariate and multivariate logistic regression analysis, preoperative Charlson Comorbidity Index (CCI) ≥2 [odds ratio (OR) =5.120, 95% confidence interval (CI): 1.193-21.985, P=0.028], right middle and/or lower lobectomy (OR =4.840, 95% CI: 1.133-20.686, P=0.033), and residual tumor in the bronchial margin (OR =4.160, 95% CI: 1.106-15.644, P=0.035) were identified as independent risk factors for postoperative BPF.

Conclusions: Although complication rate of BPF after bronchoplasty is low, the mortality of BPF is high. Patients with higher CCI, those who undergo right middle and/or lower lobectomy, and those with residual tumor in the bronchial margin are at increased risk of BPF. This study highlights the importance of preoperative evaluation and good intraoperative management to prevent this catastrophic complication.

Citing Articles

A pilot study of endobronchial repairment for bronchopleural fistulas.

Luo Z, Zheng Y, Ye G, Ma Y, Lin T, Chen C Respir Res. 2025; 26(1):55.

PMID: 39948650 PMC: 11827264. DOI: 10.1186/s12931-025-03128-6.


Prophylactic fiberoptic bronchoscopy after sleeve lobectomy can reduce the incidence of postoperative pneumonia: a propensity score matching study.

Cao J, Peng Z, Lin H, Huang Z, Liu Z, Pu Q J Thorac Dis. 2025; 16(12):8503-8512.

PMID: 39831212 PMC: 11740041. DOI: 10.21037/jtd-24-1326.


Lung autotransplantation combined with postoperative chemotherapy and immunotherapy: a three-year follow-up case report.

Wang J, Li T, Lu H, Zhao Q World J Surg Oncol. 2024; 22(1):270.

PMID: 39385204 PMC: 11462821. DOI: 10.1186/s12957-024-03545-9.


Complex Sleeve Lobectomy Has Lower Postoperative Major Complications Than Pneumonectomy in Patients with Centrally Located Non-Small-Cell Lung Cancer.

Voltolini L, Viggiano D, Gonfiotti A, Borgianni S, Mugnaini G, Salvicchi A Cancers (Basel). 2024; 16(2).

PMID: 38254752 PMC: 10813711. DOI: 10.3390/cancers16020261.


Integrated Chinese and Western Medicine in Treatment of Bronchopleural Fistula with Mycobacterium abscessus: A Case Report.

Wang Q, Cheng M, Ban C, Zhang L, Wang H, Yang B Chin J Integr Med. 2023; 30(8):742-746.

PMID: 38157117 DOI: 10.1007/s11655-023-3605-4.


References
1.
Samancilar O, Kaya S, Usluer O, Ozturk T . Neoadjuvant chemotherapy is a risk factor for bronchopleural fistula after pneumonectomy for non-small cell lung cancer. Kardiochir Torakochirurgia Pol. 2015; 11(1):40-3. PMC: 4283914. DOI: 10.5114/kitp.2014.41929. View

2.
Schirren J, Eberlein M, Fischer A, Bolukbas S . The role of sleeve resections in advanced nodal disease. Eur J Cardiothorac Surg. 2011; 40(5):1157-63. DOI: 10.1016/j.ejcts.2011.02.037. View

3.
Mammana M, Marulli G, Zuin A, Perissinotto E, Comacchio G, De Franceschi E . Postpneumonectomy bronchopleural fistula: analysis of risk factors and the role of bronchial stump coverage. Surg Today. 2019; 50(2):114-122. DOI: 10.1007/s00595-019-01871-0. View

4.
Gonzalez M, Litzistorf Y, Krueger T, Popeskou S, Matzinger O, Ris H . Impact of induction therapy on airway complications after sleeve lobectomy for lung cancer. Ann Thorac Surg. 2013; 96(1):247-52. DOI: 10.1016/j.athoracsur.2013.04.009. View

5.
Stolz A, Pafko P, Harustiak T, Smejkal M, Simonek J, Schutzner J . Risk factor analysis for early mortality and morbidity following pneumonectomy for non-small cell lung cancer. Bratisl Lek Listy. 2011; 112(4):165-9. View